Disclaimer: All biotechs are extremely risky, so do your own DD

I like this setup in CNAT . Despite the fact CNAT has recently failed a trial, I look at this as an opportunity to run before the next dataset in the 1st half of 2019.

Reasons I believe this is:

Stock has a history of filling all gaps in the chart. Gap at 4.50 currently needs to be filled.
Ascending Triangle Chart Pattern ( bullish )
Even though it temporarily made historically new lows for the stock, it subsequently rebounded off the long term support area .

Risks are as follows:

Stock offerings (although they already raised 28.6 million for trials and expenses back in May)
Failed trial

We'll see how it plays out
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Help Center Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing TradingView Coins My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out